Clinical trial
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and…
NCT00098787 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00098787 |
|---|---|
| Title | Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer |
| Official title | Phase II Study of Treatment Selection Based Upon Tumor Thymidylate Synthase Expression in Previously Untreated Patients With Metastatic Colorectal Cancer |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Biological, Drug |
| Interventions | bevacizumab, fluorouracil, irinotecan hydrochloride, leucovorin calcium, Oxaliplatin |
| Enrollment | 247 |
| Start date | Sep 8, 2005 |
| Primary completion | Nov 1, 2013 |
| Completion | Apr 1, 2015 |
| First posted | Dec 9, 2004 |
| Last update posted | Jul 5, 2023 |
| Countries | United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: